Come up with a name for your new list and we'll add to it:
ApoCell raised a round of funding on November 13, 2013. Investors include
National Cancer Institute.
ApoCell is a privately-held specialty clinical research company. Founded in 2004, the firm is a provider in molecular biomarker detection and analysis, leveraging its expertise in the areas of oncolog…